Literature DB >> 1391807

Ultrastructural analysis of platelet-like particles from a human megakaryocytic leukemia cell line (CMK 11-5).

T Nagano1, S Ohga, Y Kishimoto, T Kimura, K Yasunaga, M Adachi, R Ryo, T Sato.   

Abstract

Ultrastructural observations were performed to further characterize the human megakaryocytic leukemia cell line, CMK, and its subclone, CMK11-5. We found that particles derived from CMK11-5 cells had cytoplasmic projections and no nucleus, and that some particles contained alpha granules. Incubation with ADP induced fibrinogen receptors on the surface of these particles. Furthermore, the particles had glycoprotein Ib antigen on their surfaces, and attached nonreversibly to rabbit aortic subendothelium, showing associated morphological changes similar to those observed in normal platelets. CMK and CMK11-5 are the first megakaryocytic cell lines that have been found to release particles that have some of the same functions as normal platelets. In particular, CMK11-5 seems to be a useful model for studying megakaryocyte function.

Entities:  

Mesh:

Year:  1992        PMID: 1391807

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  3 in total

1.  High-Throughput Production of Platelet-Like Particles.

Authors:  Kylie M Persson; Pauline V Kneller; Mark W Livingston; Lucas M Bush; Tara L Deans
Journal:  Methods Mol Biol       Date:  2021

2.  Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib.

Authors:  K Shide; T Kameda; T Yamaji; M Sekine; N Inada; A Kamiunten; K Akizuki; K Nakamura; T Hidaka; Y Kubuki; H Shimoda; A Kitanaka; A Honda; A Sawaguchi; H Abe; T Miike; H Iwakiri; Y Tahara; M Sueta; S Hasuike; S Yamamoto; K Nagata; K Shimoda
Journal:  Leukemia       Date:  2016-11-03       Impact factor: 11.528

Review 3.  Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling.

Authors:  Nikhil Rangholia; Tina M Leisner; Stephen P Holly
Journal:  Metabolites       Date:  2021-01-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.